Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Dermatomyositis is a chronic autoimmune disease characterised by muscle weakness, skin lesions, and systemic complications.

IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline. The company (IGMS) had 198 ...

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Guam Regional Medical City is excited to announce the addition of Dr. Supannee "Jill' Rassameehiran, a board-certified ...

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...